- Home
- XENE vs CPRI Comparison
XENE vs CPRI Comparison
Compare XENE & CPRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XENE | CPRI |
|---|---|---|
| Founded | 1996 | 1981 |
| Country | Canada | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.2B |
| IPO Year | 2014 | 2011 |
Fundamental Metrics
Financial Performance| Metric | XENE | CPRI |
|---|---|---|
| Price | $43.74 | $26.00 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 11 |
| Target Price | ★ $53.91 | $26.36 |
| AVG Volume (30 Days) | 793.2K | ★ 2.7M |
| Earning Date | 11-03-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $7,500,000.00 | ★ $4,369,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.99 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $26.74 | $11.86 |
| 52 Week High | $46.60 | $28.27 |
Technical Indicators
Market Signals| Indicator | XENE | CPRI |
|---|---|---|
| Relative Strength Index (RSI) | 56.74 | 60.55 |
| Support Level | $42.89 | $25.64 |
| Resistance Level | $44.57 | $27.00 |
| Average True Range (ATR) | 1.42 | 0.96 |
| MACD | -0.07 | -0.06 |
| Stochastic Oscillator | 32.63 | 43.74 |
Price Performance
Historical ComparisonAbout XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
About CPRI Capri Holdings Limited
Capri Holdings is a marketer, distributor, and retailer of upscale accessories and apparel in the Americas, Europe, and Asia. Michael Kors, Capri's original and largest brand by sales, offers handbags, footwear, and apparel through more than 700 company-owned stores, wholesale, and e-commerce. Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. Its products are sold in more than 200 company-operated stores. Capri also owns a third brand, Versace, but has agreed to sell it to Prada. John Idol has served as Capri's CEO since 2003.